Mefenamic acid

This classification denotes a nonsteroidal antiinflammatory drug with the molecular formula C15H15NO2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 367589PJ2C, chemically known as 2-diphenylaminecarboxylic acid, 2,3-dimethyl- but generally known as mefenamic acid, which bears US NIH Compound Identifier 4044. European Medicines Agency schedules Mefenamic acid in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08703MIG. The term MEFENAMIC ACID is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 28, No. 10 1974, List 14). World Health Organization schedules mefenamic acid in its Anatomical Therapeutic Chemical (ATC) Classification. Most nations schedule mefenamic acid under HS 29224995 and SITC 51465. As of Q4 2014, MEFENAMIC ACID remains the US FDA Preferred Term for this commodity. Mefenamic acid bears US NLM identifiers UMLS ID C0025152 and NCI Concept Code C47599. SMILES: OC(=O)C1C(NC2C(C(CCC2)C)C)CCCC1.